Preferred Label : Celecoxib;
MeSH definition : A pyrazole derivative and selective CYCLOOXYGENASE 2 INHIBITOR that is used to treat
symptoms associated with RHEUMATOID ARTHRITIS; OSTEOARTHRITIS and JUVENILE ARTHRITIS,
as well as the management of ACUTE PAIN.;
MeSH synonym : 4-(5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide;
CISMeF synonym : 58635, SC;
MeSH hyponym : SC 58635; celebrex; SC-58635; SC58635;
MeSH Related Number : 169590-42-5;
Is substance : O;
UNII : JCX84Q7J1L;
Origin ID : D000068579;
UMLS CUI : C0538927;
ATC code(s)
ATC code(s)
Allowable qualifiers
CISMeF manual mappings
Currated CISMeF NLP mapping
Pharmacological action(s)
Record concept(s)
Related MeSH Supplementary Concept(s)
See also inter- (CISMeF)
Semantic type(s)
UMLS correspondences (same concept)
Validated automatic mappings to BTNT
A pyrazole derivative and selective CYCLOOXYGENASE 2 INHIBITOR that is used to treat
symptoms associated with RHEUMATOID ARTHRITIS; OSTEOARTHRITIS and JUVENILE ARTHRITIS,
as well as the management of ACUTE PAIN.
Benefits and harms of celecoxib to treat people with osteoarthritis
http://www.cochrane.org/fr/CD009865/benefices-et-effets-indesirables-du-celecoxib-dans-le-traitement-des-personnes-souffrant-darthrose
2017
false
false
false
France
United Kingdom
French
English
french abstract
Celecoxib
Celecoxib
celecoxib
cyclooxygenase 2 inhibitors
cyclooxygenase 2 inhibitors
osteoarthritis
treatment outcome
quality of life
comparative effectiveness research
adult
review of literature
Evidence-Based medicine
---
http://www.cochrane.org/fr/CD012095/les-benefices-et-les-inconvenients-du-celecoxib-pour-le-traitement-des-personnes-ayant-une
2017
false
false
false
France
United Kingdom
French
french abstract
arthritis, rheumatoid
Celecoxib
anti-inflammatory agents, non-steroidal
review of literature
Celecoxib
anti-inflammatory agents, non-steroidal
---
Summary Safety Review - Celecoxib (CELEBREX and generics) - Assessing the Risk of
Serious Heart and Stroke Side Effects at High Doses Relative to Other Non-Steroidal
Anti-Inflammatory Drugs (NSAIDs)
https://www.hc-sc.gc.ca/dhp-mps/medeff/reviews-examens/celecoxib-fra.php
2016
false
false
false
Canada
French
English
risk assessment
Celecoxib
celecoxib
stroke
heart diseases
High dose (qualifier value)
Celecoxib
anti-inflammatory agents, non-steroidal
anti-inflammatory agents, non-steroidal
administration, oral
Evidence-Based medicine
pharmacovigilance note
Long-term drug therapy (procedure)
---
http://www.cochrane.org/fr/CD007744/tolerabilite-des-inhibiteurs-selectifs-de-la-cyclo-oxygenase-2-cox-2-utilises-dans-le-traitement-des-manifestations-rhumatologiques-des-maladies-inflammatoires-de-lintestin
2014
false
false
false
France
United Kingdom
French
review of literature
cyclooxygenase 2 inhibitors
musculoskeletal diseases
french abstract
treatment outcome
Celecoxib
Celecoxib
celecoxib
etoricoxib
inflammatory bowel diseases
cyclooxygenase 2 inhibitors
pyridines
sulfones
pyridines
sulfones
Etoricoxib
Etoricoxib
---
http://www.lecrat.eu/?s=C%C3%A9l%C3%A9coxib
2013
false
France
French
Celecoxib
pregnancy
anti-inflammatory agents, non-steroidal
cyclooxygenase inhibitors
celecoxib
drug information
---
http://www.cochrane.org/fr/CD004233
2013
false
United Kingdom
France
French
Celecoxib
meta-analysis
treatment outcome
adult
pain, postoperative
administration, oral
cyclooxygenase 2 inhibitors
acute pain
french abstract
---
http://www.lecrat.eu/?s=Etat+des+connaissances+sur+le+c%C3%A9l%C3%A9coxib
2013
false
France
French
Celecoxib
drug information
teratogens
celecoxib
pregnancy
fetus
Product containing celecoxib (medicinal product)
cyclooxygenase 2 inhibitors
---
http://www.has-sante.fr/portail/jcms/c_1215844/celebrex
http://www.has-sante.fr/portail/upload/docs/application/pdf/2012-02/celebrex_18012012_ct10645.pdf
http://www.has-sante.fr/portail/jcms/c_874882/celebrex
http://www.has-sante.fr/portail/jcms/c_1013257/celebrex
2012
false
France
French
Celecoxib
administration, oral
cyclooxygenase 2 inhibitors
celecoxib
osteoarthritis
arthritis, rheumatoid
spondylitis, ankylosing
treatment outcome
adult
aged
pregnancy
insurance, health, reimbursement
cyclooxygenase 2 inhibitors
evaluation of the transparency committee
---
https://www.ema.europa.eu/medicines/human/EPAR/Onsenal
2011
false
United Kingdom
English
French
syndication feed
Celecoxib
Celecoxib
drug approval
drug labeling
capsules
administration, oral
adenomatous polyposis coli
pregnancy
orphan drug production
drug interactions
breast feeding
cyclooxygenase 2 inhibitors
cyclooxygenase 2 inhibitors
drug evaluation, preclinical
continuity of patient care
adenomatous polyposis coli
adenomatous polyposis coli
adult
anti-inflammatory agents, non-steroidal
anti-inflammatory agents, non-steroidal
celecoxib
summary of product characteristics
package leaflet
---
http://www.has-sante.fr/portail/jcms/c_1032349/celebrex-celecoxib-ains
http://www.has-sante.fr/portail/upload/docs/application/pdf/2011-01/celebrex_-_ct-8337.pdf
2010
false
France
French
Celecoxib
Celecoxib
adult
aged
cyclooxygenase 2 inhibitors
administration, oral
celecoxib
cyclooxygenase 2 inhibitors
osteoarthritis
arthritis, rheumatoid
spondylitis, ankylosing
treatment outcome
evaluation of the transparency committee
guidelines for drug use
---
https://minerva-ebp.be/fr/article/478
2008
false
minerva-ebm.be
Belgium
French
cardiovascular risk
Celecoxib
Celecoxib
cardiovascular diseases
risk
treatment outcome
cyclooxygenase inhibitors
critical appraisal or critical reading
---
http://www.stacommunications.com/journals/leclinicien/2008/08-Septembre%202008/064-Coxibs%20et%20AINS.pdf
2008
false
Canada
French
Celecoxib
Celecoxib
anti-inflammatory agents, non-steroidal
journal article
---
http://www.fmoq.org/Lists/FMOQDocumentLibrary/fr/Le%20M%C3%A9decin%20du%20Qu%C3%A9bec/Archives/2000%20-%202009/023-027InfoPoems0107.pdf
2007
false
false
Canada
French
corticosteroid therapy
antibiotic therapy
Celecoxib
Mometasone Furoate
rhinitis
sinusitis
administration, intranasal
anti-inflammatory agents
cyclooxygenase 2 inhibitors
naproxen
proton pump inhibitors
drug therapy, combination
peptic ulcer
colorectal neoplasms
colorectal neoplasms
dietary fiber
anti-bacterial agents
otitis media
patient participation
parents
Evidence-Based medicine
treatment outcome
breast neoplasms
estrogen replacement therapy
postmenopause
breast neoplasms
incidence
risk factors
critical appraisal or critical reading
Rhinosinusitis
---
https://www.cadth.ca/sites/default/files/pdf/ews10_cetap_f.pdf
https://www.cadth.ca/sites/default/files/pdf/ews10_cetap_e.pdf
1999
false
Canada
French
English
Celecoxib
rofecoxib
alzheimer disease
canada
treatment outcome
anti-inflammatory agents, non-steroidal
Evidence-Based medicine
sulfones
lactones
coxibs
lactones
sulfones
drug evaluation
---